Speaker illustration

Doctor Stefanos Zafeiropoulos

The Feinstein Institutes for Medical Research, Manhasset (United States of America)

Member of:

European Society of Cardiology

Stefanos Zafeiropoulos is a PhD Student in the Elmezzi Graduate School in the Feinstein Institutes for Medical Research. He focuses on vagus nerve stimulation in pulmonary hypertension and right heart failure. He completed his residency in internal Medicine in Greece and after his PhD completion, he will pursue a fellowship in Cardiology. He had worked as a research assistant at the Department of Cardiology in AHEPA hospital (Greece) and engaged in research and clinical trials. He had also completed with first class honors a MSc Programm named Medical Research Methodology provided by Aristotle University of Thessaloniki. Dr Zafeiropoulos graduated in 2018 with first class honors by the Medical School of Aristotle University in Thessaloniki and he completed part of his undergraduate education in Germany (Freiburg and Bochum). He has served as Secretary General and Vice President in Panhellenic board of Scientific Society of Hellenic Medical Students.

Stellate ganglion blockade for treatment of ventricular arrhythmia storm: A meta-analysis

Event: ESC Congress 2022

Topic: Treatment

Session: Interventional treatment for ventricular tachycardia in structural heart disease: new approaches for better outcome?

Thumbnail

Focused ultrasound stimulation of the inflammatory reflex at the spleen ameliorates pulmonary arterial hypertension in rodents

Event: ESC Congress 2022

Topic: Hypertension, Pulmonary Hypertension

Session: New insights and therapeutic options in pulmonary arterial hypertension

Thumbnail

Predictors of all-cause mortality within and beyond 1 year after an acute coronary syndrome

Event: ESC Preventive Cardiology 2021

Topic: Epidemiology, Prognosis, Outcome

Session: ePosters

Thumbnail

Predictive role of platelet indices on hospital admission and discharge in the long-term prognosis of acute coronary syndrome: Platelets do count.

Event: ESC Preventive Cardiology 2021

Topic: Epidemiology, Prognosis, Outcome

Session: ePosters

Thumbnail

Risk for recurrent cardiovascular events and expected risk reduction with optimal treatment one year after an acute coronary syndrome

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Secondary Prevention

Session: Risk Factors and Prevention ePosters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk